# NHS National Proprietary Pharmaceuticals - Eculizumab biosimilar

> Pre-procurement notice from UK public-sector procurement sources.

## Key facts

- Public buyer: [NHS England](/buyers/nhs-england/contract-awards)
- Tender value: £74,000,000
- Published: 5 December 2022
- Planned start: 1 December 2023
- Planned end: 30 November 2024
- Stage: pre_procurement
- Procurement category: goods
- Notice ID: 672d9438-6f24-4059-bbbd-ff64b230bfda-595976
- OCID: ocds-b5fd17-044c0f20-073f-4bf9-859a-c295acdd7e63

## Description

CM/PHR/22/5693 NHS National Proprietary Pharmaceuticals - Eculizumab biosimilar

## Related contract awards

- [Identity Access Management - Service Adoption and Enablement](/contracts/ocds-b5fd17-08ebad6c-84fb-4e62-9afd-d06d220dd3a5): NHS England
- [OutSystems licenses for MAPPTI \(AP&P\)](/contracts/ocds-b5fd17-521fbf90-6e93-4366-b3bc-47aa2efd447d): NHS England
- [Provision of national e-portfolio 26/27](/contracts/ocds-b5fd17-7e027849-39ea-4eb8-8eb0-3b38f18dcca4): NHS England

## Source

[View the original notice on Contracts Finder](https://www.contractsfinder.service.gov.uk/Notice/672d9438-6f24-4059-bbbd-ff64b230bfda-595976)